IL4 and allergic disease: In the present study, we observed that the oral administration of the IJH-SONE68-derived EPS represses the expression of IL-4 and serum IgE accelerated in the PiCl-induced delayed-type allergy model mice, suggesting that the IJH-SONE68-derived EPS is effective to improve both types of allergic reactions.